Gilbert et al. found that angiotensin converting enzyme inhibition and angiotensin receptor blockade could reduce the development and progression of diabetic nephropathy, cardiovascular disease, and possibly retinopathy (Gilbert et al., 2003). This evidence concerns the gene ACE and diabetic kidney disease.